Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Shulman

Showing results (381-390 of 422) with videos related to

Pageof 43
Sort By:
Pediatric Blood & Cancer|January 12, 2026
Treatment and Outcomes of Children and Adults With Rhabdomyosarcoma in RwandaOscar Nsanzimana, Kendall Carpenter, Chandler Villaverde, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 13, 2022
Circulating Tumor DNA Is Associated with Response and Survival in Patients with Advanced LeiomyosarcomaLaura M Madanat-Harjuoja, Kelly Klega, Yao Lu, et al.
Gastroenterology|March 16, 2016
Efficacy of Direct-Acting Antiviral Combination for Patients With Hepatitis C Virus Genotype 1 Infection and Severe Renal Impairment or End-Stage Renal DiseasePaul J Pockros, K Rajender Reddy, Parvez S Mantry, et al.
British Journal of Cancer|October 11, 2022
Adverse prognostic impact of the loss of STAG2 protein expression in patients with newly diagnosed localised Ewing sarcoma: A report from the Children's Oncology GroupDavid S Shulman, Sonja Chen, David Hall, et al.
Cancer Medicine|November 27, 2025
A Phase 1 Trial of Fimepinostat in Children and Adolescents With Relapsed and Refractory Solid and CNS TumorsDavid S Shulman, Kieuhoa T Vo, Frank M Balis, et al.
Kidney International Reports|February 19, 2019
Efficacy and Safety of Ombitasvir/Paritaprevir/Ritonavir in Patients With Hepatitis C Virus Genotype 1 or 4 Infection and Advanced Kidney DiseaseEric Lawitz, Edward Gane, Eric Cohen, et al.
Cancer Medicine|June 12, 2023
Phase 2 trial of palbociclib and ganitumab in patients with relapsed Ewing sarcomaDavid S Shulman, Priscilla Merriam, Edwin Choy, et al.
Gastroenterology|January 18, 2012
Effect of IL28B genotype on early viral kinetics during interferon-free treatment of patients with chronic hepatitis CTom W Chu, Rohit Kulkarni, Edward J Gane, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 30, 2021
Multicenter Analysis of Genomically Targeted Single Patient Use Requests for Pediatric NeoplasmsHimalee S Sabnis, David S Shulman, Benjamin Mizukawa, et al.
Antimicrobial Agents and Chemotherapy|December 4, 2013
Efficacy and safety of danoprevir-ritonavir plus peginterferon alfa-2a-ribavirin in hepatitis C virus genotype 1 prior null respondersEdward J Gane, Régine Rouzier, Alicja Wiercinska-Drapalo, et al.
Pageof 43

Showing results (381-390 of 422) with videos related to

Sort By:
Pageof 43
Pediatric Blood & Cancer|January 12, 2026
Treatment and Outcomes of Children and Adults With Rhabdomyosarcoma in RwandaOscar Nsanzimana, Kendall Carpenter, Chandler Villaverde, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 13, 2022
Circulating Tumor DNA Is Associated with Response and Survival in Patients with Advanced LeiomyosarcomaLaura M Madanat-Harjuoja, Kelly Klega, Yao Lu, et al.
Gastroenterology|March 16, 2016
Efficacy of Direct-Acting Antiviral Combination for Patients With Hepatitis C Virus Genotype 1 Infection and Severe Renal Impairment or End-Stage Renal DiseasePaul J Pockros, K Rajender Reddy, Parvez S Mantry, et al.
British Journal of Cancer|October 11, 2022
Adverse prognostic impact of the loss of STAG2 protein expression in patients with newly diagnosed localised Ewing sarcoma: A report from the Children's Oncology GroupDavid S Shulman, Sonja Chen, David Hall, et al.
Cancer Medicine|November 27, 2025
A Phase 1 Trial of Fimepinostat in Children and Adolescents With Relapsed and Refractory Solid and CNS TumorsDavid S Shulman, Kieuhoa T Vo, Frank M Balis, et al.
Kidney International Reports|February 19, 2019
Efficacy and Safety of Ombitasvir/Paritaprevir/Ritonavir in Patients With Hepatitis C Virus Genotype 1 or 4 Infection and Advanced Kidney DiseaseEric Lawitz, Edward Gane, Eric Cohen, et al.
Cancer Medicine|June 12, 2023
Phase 2 trial of palbociclib and ganitumab in patients with relapsed Ewing sarcomaDavid S Shulman, Priscilla Merriam, Edwin Choy, et al.
Gastroenterology|January 18, 2012
Effect of IL28B genotype on early viral kinetics during interferon-free treatment of patients with chronic hepatitis CTom W Chu, Rohit Kulkarni, Edward J Gane, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 30, 2021
Multicenter Analysis of Genomically Targeted Single Patient Use Requests for Pediatric NeoplasmsHimalee S Sabnis, David S Shulman, Benjamin Mizukawa, et al.
Antimicrobial Agents and Chemotherapy|December 4, 2013
Efficacy and safety of danoprevir-ritonavir plus peginterferon alfa-2a-ribavirin in hepatitis C virus genotype 1 prior null respondersEdward J Gane, Régine Rouzier, Alicja Wiercinska-Drapalo, et al.
Pageof 43